Empresa ImmunoGen, Inc.
Acciones
IMGN
US45253H1014
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 277
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Lauren White
DFI | Director of Finance/CFO | 45 | 18/09/23 |
Robert Herbst
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | 61 | 04/01/23 | |
Anabel Chan
IRC | Investor Relations Contact | - | - |
Isabel Kalofonos
PRN | Corporate Officer/Principal | 53 | 24/04/23 |
Renee Lentini
AUD | Comptroller/Controller/Auditor | 46 | 01/01/04 |
Stacy Coen
PRN | Corporate Officer/Principal | 53 | 03/06/20 |
Joseph J. Kenny
LAW | General Counsel | - | 01/01/09 |
Audrey Bergan
HRO | Human Resources Officer | - | 01/01/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 279 354 016 | 279 140 089 ( 99,92 %) | 0 | 99,92 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,51 % | 42,59 mil M | |
+8,57 % | 40,65 mil M | |
+49,22 % | 40,57 mil M | |
-12,36 % | 26,77 mil M | |
+8,92 % | 24,81 mil M | |
-25,13 % | 18,17 mil M | |
+29,17 % | 12,05 mil M | |
-3,12 % | 11,7 mil M | |
+6,35 % | 11,1 mil M |